Cite
HARVARD Citation
Shaik, J. et al. (2019). A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls. Clinical pharmacology in drug development. 8 (5), pp. 664-673. [Online].